ArticleClinical pharmacology and therapeutics2023

Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pharmacokinetics in HER2-Positive or HER2-Low Metastatic/Unresectable Breast Cancer.

Akihiko Shimomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.